Charles Dobard

1.1k total citations
31 papers, 874 citations indexed

About

Charles Dobard is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Charles Dobard has authored 31 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 25 papers in Virology and 12 papers in Epidemiology. Recurrent topics in Charles Dobard's work include HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (22 papers) and HIV/AIDS drug development and treatment (11 papers). Charles Dobard is often cited by papers focused on HIV Research and Treatment (25 papers), HIV/AIDS Research and Interventions (22 papers) and HIV/AIDS drug development and treatment (11 papers). Charles Dobard collaborates with scholars based in United States, Uganda and Switzerland. Charles Dobard's co-authors include Samson A. Chow, Walid Heneine, Kai Zhu, J. Gerardo Garcı́a-Lerma, Sunita Sharma, Debra L. Hanson, Ellen N. Kersh, Patricia C. Guenthner, Francis J. Novembre and Ron A. Otten and has published in prestigious journals such as PLoS ONE, Journal of Virology and The Journal of Infectious Diseases.

In The Last Decade

Charles Dobard

29 papers receiving 863 citations

Peers

Charles Dobard
Nicola Richardson‐Harman United States
Urvi M. Parikh United States
Artur Ramos United States
Meropi Aravantinou United States
Wes Rountree United States
Nina Derby United States
Viktor Dahl Sweden
Jonathan Lipscomb United States
Omu Anzala Kenya
Eddie Jackson United States
Nicola Richardson‐Harman United States
Charles Dobard
Citations per year, relative to Charles Dobard Charles Dobard (= 1×) peers Nicola Richardson‐Harman

Countries citing papers authored by Charles Dobard

Since Specialization
Citations

This map shows the geographic impact of Charles Dobard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles Dobard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles Dobard more than expected).

Fields of papers citing papers by Charles Dobard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charles Dobard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles Dobard. The network helps show where Charles Dobard may publish in the future.

Co-authorship network of co-authors of Charles Dobard

This figure shows the co-authorship network connecting the top 25 collaborators of Charles Dobard. A scholar is included among the top collaborators of Charles Dobard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charles Dobard. Charles Dobard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Massud, Ivana, Kenji Nishiura, Susan Ruone, et al.. (2024). Weekly Oral Tenofovir Alafenamide Protects Macaques from Vaginal and Rectal Simian HIV Infection. Pharmaceutics. 16(3). 384–384.
3.
Daly, Michele B., Lingying Li, Sai Archana Krovi, et al.. (2023). Pharmacokinetic Study of Islatravir and Etonogestrel Implants in Macaques. Pharmaceutics. 15(12). 2676–2676. 2 indexed citations
4.
Dobard, Charles, M. Melissa Peet, Kenji Nishiura, et al.. (2022). Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques. EBioMedicine. 86. 104361–104361. 11 indexed citations
5.
Gatto, Gregory J., Sai Archana Krovi, Lei Li, et al.. (2022). Comparative Pharmacokinetics and Local Tolerance of Tenofovir Alafenamide (TAF) From Subcutaneous Implant in Rabbits, Dogs, and Macaques. Frontiers in Pharmacology. 13. 923954–923954. 10 indexed citations
6.
Massud, Ivana, Sai Archana Krovi, Kenji Nishiura, et al.. (2022). Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model. Journal of Antimicrobial Chemotherapy. 77(11). 2964–2971. 7 indexed citations
7.
Romano, Joseph, Marc M. Baum, Charles Dobard, et al.. (2021). Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting. AIDS Research and Human Retroviruses. 37(6). 409–420. 19 indexed citations
8.
Daly, Michele B., Angela Holder, Chuong Dinh, et al.. (2020). The effect of depot medroxyprogesterone acetate on tenofovir alafenamide in rhesus macaques. Antiviral Research. 186. 105001–105001. 2 indexed citations
9.
Garber, David A., James Mitchell, Debra Adams, et al.. (2018). Development of a repeat-exposure penile SHIV infection model in macaques to evaluate biomedical preventions against HIV. PLoS ONE. 13(3). e0194837–e0194837. 7 indexed citations
10.
Makarova, Natalia, Tara Henning, Chuong Dinh, et al.. (2017). Topical tenofovir protects against vaginal simian HIV infection in macaques coinfected with Chlamydia trachomatis and Trichomonas vaginalis. AIDS. 31(6). 745–752. 12 indexed citations
11.
12.
Kersh, Ellen N., Tara Henning, Charles Dobard, Walid Heneine, & Janet M. McNicholl. (2015). Short Communication: Practical Experience with Analysis and Design of Repeat Low-Dose SHIV SF162P3 Exposure Studies in Female Pigtail Macaques with Varying Susceptibility During Menstrual Cycling. AIDS Research and Human Retroviruses. 31(11). 1166–1169. 3 indexed citations
13.
Tsegaye, Theodros Solomon, Katherine Butler, Wei Luo, et al.. (2015). Repeated Vaginal SHIV Challenges in Macaques Receiving Oral or Topical Preexposure Prophylaxis Induce Virus-Specific T-Cell Responses. JAIDS Journal of Acquired Immune Deficiency Syndromes. 69(4). 385–394. 6 indexed citations
14.
Dobard, Charles, Sunita Sharma, Peter L. Anderson, et al.. (2015). Protection Against Rectal Chimeric Simian/Human Immunodeficiency Virus Transmission in Macaques by Rectal-Specific Gel Formulations of Maraviroc and Tenofovir. The Journal of Infectious Diseases. 212(12). 1988–1995. 24 indexed citations
15.
Dobard, Charles, Sunita Sharma, Mian‐er Cong, et al.. (2015). Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques. Retrovirology. 12(1). 69–69. 11 indexed citations
16.
Henning, Tara, Debra L. Hanson, Sundaram A. Vishwanathan, et al.. (2014). Short Communication: Viremic Control Is Independent of Repeated Low-Dose SHIV SF162p3 Exposures. AIDS Research and Human Retroviruses. 30(11). 1125–1129. 3 indexed citations
17.
Dobard, Charles, Sunita Sharma, Chou‐Pong Pau, et al.. (2014). Rectal Specific Gels Containing Maraviroc and/or Tenofovir Protect against Rectal SHIV Transmission in a Macaque Model. AIDS Research and Human Retroviruses. 30(S1). A13–A14. 3 indexed citations
18.
Cong, Mian-er, Ae S. Youngpairoj, Wutyi Aung, et al.. (2011). Generation and mucosal transmissibility of emtricitabine- and tenofovir-resistant SHIV162P3 mutants in macaques. Virology. 412(2). 435–440. 13 indexed citations
19.
Vishwanathan, Sundaram A., Patricia C. Guenthner, Carol Y. Lin, et al.. (2011). High Susceptibility to Repeated, Low-Dose, Vaginal SHIV Exposure Late in the Luteal Phase of the Menstrual Cycle of Pigtail Macaques. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(4). 261–264. 115 indexed citations
20.
Dobard, Charles, et al.. (2010). Role of Human Immunodeficiency Virus Type 1 Integrase in Uncoating of the Viral Core. Journal of Virology. 84(10). 5181–5190. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicola Richardson‐Harman Breakdown of academic impact, for papers by Urvi M. Parikh Breakdown of academic impact, for papers by Artur Ramos Breakdown of academic impact, for papers by Meropi Aravantinou Breakdown of academic impact, for papers by Wes Rountree Breakdown of academic impact, for papers by Nina Derby Breakdown of academic impact, for papers by Viktor Dahl Breakdown of academic impact, for papers by Jonathan Lipscomb Breakdown of academic impact, for papers by Omu Anzala Breakdown of academic impact, for papers by Eddie Jackson
Rankless by CCL
2026